Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05475574

Impact of Discontinuing Contact Precautions for Extended-spectrum β-lactamase Enterobacteriaceae in a Geriatric Unit

Impact of Discontinuing Contact Precautions for Extended-spectrum β-lactamase Enterobacteriaceae (ESBLE) in a Geriatric Unit: an Interventional Prospective Noninferiority Non-randomized Double-blind Controlled Before and After Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
954 (estimated)
Sponsor
Centre Hospitalier Régional Metz-Thionville · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

This is an interventional multicenter prospective noninferiority non-randomized double-blind controlled before and after study. The aim of this study is to demonstrate that standard precautions alone are not inferior to contact precautions by comparing the incidence density of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae acquired in geriatric units before and after discontinuing contact precautions.

Detailed description

Healthcare-associated infections (HAIs) are one of the main causes of morbidity and mortality worldwide. Extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae have become microorganisms frequently found in HAIs, which reduces the therapeutic possibilities.

Conditions

Interventions

TypeNameDescription
OTHERDiscontinuation of contact precautions for ESBLEDiscontinuation of contact precaution : only standard precaution are implemented for any patient carrying (infected or colonized) ESBLE

Timeline

Start date
2023-03-07
Primary completion
2029-09-07
Completion
2029-09-21
First posted
2022-07-27
Last updated
2025-04-27

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05475574. Inclusion in this directory is not an endorsement.